LADENBURG THALMANN FINANCIAL SERVICES INC. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$7,0000.0%113
-7.4%
0.00%
Q3 2019$7,000
+250.0%
122
+190.5%
0.00%
Q2 2019$2,0000.0%420.0%0.00%
Q1 2019$2,000
-33.3%
42
-44.0%
0.00%
Q4 2018$3,000
-70.0%
75
-47.2%
0.00%
Q3 2018$10,000
-94.4%
142
-95.8%
0.00%
-100.0%
Q2 2018$178,0000.0%3,3990.0%0.00%0.0%
Q1 2018$178,000
-0.6%
3,399
+1.5%
0.00%0.0%
Q4 2017$179,000
-11.8%
3,3490.0%0.00%0.0%
Q3 2017$203,000
-22.2%
3,349
+0.9%
0.00%
-33.3%
Q2 2017$261,000
-4.7%
3,318
+0.5%
0.00%0.0%
Q1 2017$274,000
+4.6%
3,3000.0%0.00%
-25.0%
Q4 2016$262,000
+13.4%
3,3000.0%0.00%
+33.3%
Q3 2016$231,000
+75.0%
3,300
-1.5%
0.00%
+50.0%
Q2 2016$132,000
+6500.0%
3,350
+6600.0%
0.00%
Q1 2016$2,000
-50.0%
500.0%0.00%
Q4 2015$4,000
-87.9%
50
-87.7%
0.00%
-100.0%
Q2 2015$33,0004050.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders